Literature DB >> 8493990

Factor V inhibitor in thrombosis.

A Kapur1, P R Kelsey, P E Isaacs.   

Abstract

A 68-year-old previously well woman developed sudden onset of limb gangrene in association with liver dysfunction. An immediately acting inhibitor to factor V with some of the features of lupus anticoagulant was demonstrated. The patient required limb amputation within 2 weeks and activity of the anticoagulant seemed to be on the decline 6 months later.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8493990     DOI： 10.1002/ajh.2830420410

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  8 in total

Review 1.  Acquired factor V inhibitors: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

2.  Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.

Authors:  B Dahlbäck; B Hildebrand
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

3.  Transient cefuroxime/metronidazole treatment induced factor V antibodies.

Authors:  Sjoerd Adrianus Antonius Van den Berg; Patricia E Verwer; René N Idema; Coen Van Guldener
Journal:  BMJ Case Rep       Date:  2014-08-19

4.  Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.

Authors:  T L Ortel; M C Mercer; E H Thames; K D Moore; J H Lawson
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

5.  A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis.

Authors:  Hina Ogawa; Masayoshi Souri; Kazunori Kanouchi; Tsukasa Osaki; Rie Ohkubo; Tomoko Kawanishi; Sachiko Wakai; Keita Morikane; Akitada Ichinose
Journal:  Int J Hematol       Date:  2018-11-16       Impact factor: 2.490

6.  Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression.

Authors:  B Tribl; P Knöbl; K Derfler; S Kapiotis; G Aspöck; U Jäger; W Hörl; K Lechner
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

7.  Acquired factor V inhibitor in a patient with mantle cell lymphoma presenting with hematuria followed by thrombosis: a case report.

Authors:  Naif I Aljohani; John H Matthews
Journal:  Int Med Case Rep J       Date:  2014-02-24

8.  Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.

Authors:  Xiangyu Wang; Xuemei Qin; Yuan Yu; Ran Wang; Xinguang Liu; Min Ji; Minran Zhou; Chunyan Chen
Journal:  Blood Coagul Fibrinolysis       Date:  2017-06       Impact factor: 1.276
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.